Artigo original que será publicado na Newsletter Bariatric Times lido por milhares de cirurgiões bariátricos no mundo, incluindo EUA e Europa.

The field of metabolic/diabetes surgery maturing. It was time to organize a meeting that would focus directly on the science that supports metabolic surgery, evolving from basic science and exploring the mechanisms of action of different operations, to a panel consensus, covering all surgical procedures, from the traditional to the novel. To accomplish this, an amazing worldclass faculty was put together in Sao Paulo, Brazil, at the First Panamerican Meeting on Diabetes Surgery, November 14–16, 2009. About 1,700 attendees hailing from all over of the world, including the Americas, Europe, and Asia, actively participated during sessions. Drs. Ricardo Cohen, Luis Berti, and Thomas Szego organized a comprehensive program that was part of the XI National Meeting of The Brazilian Society of Bariatric and Metabolic Surgery (SBCBM), the world’s second largest bariatric surgery society.

An overview of today’s modern medical approaches to type 2 diabetes melitus (T2DM) and the role of incretins in T2DM started the sessions.

We had many bright stars among the basic science tract. Among several, Samuel Klein, Blandine Laferrere, Francesco Rubino, David Cummings,from the United States, and Gilles Mithieux showed their respective landmark works on the antidiabetic effect being surgically achieved, independent of weight loss. Josep Vidal and Antonio Lacy from Spain discussed the underlying hormonal mechanisms that may be behind the effectiveness of the sleeve gastrectomy. We have not forgotten the effects of decreasing mortality after bariatric/metabolic surgery. Ted Adams and David Flum led the presentations on that subject.

Nicola Scopinaro, Sayeed Ikkramudin, Scott Shikora, and John Dixon presented on traditional bariatric procedures that may be employed with good results when treating type 2 diabetes mellitus. Surgery for patients with a body mass index (BMI) less than 35kg/m2 was highlighted. The role of the Roux-en-Y gastric bypass and novel procedures, such as duodenal jejunal bypass with or without a sleeve gastrectomy, ileal transposition, and the sleeve gastrectomy as a standalone procedure, to treat T2DM were elegantly presented as well.

The final session included an audience electronic vote session on The Brazilian Society of Bariatric and Metabolic Surgery consensus statatements on how T2DM surgery should be conducted in Brazi.

The 1st Panamerican Meeting on Diabetes Surgery was a success. and we invite you all to attend the second meeting, which will be held in a natural sanctuary in a protected environment in Bonito, Brazil, November 17–20, 2010.

For more information on the cutting-edge T2DM surgery science and the natural resources of Bonito, Brazile, visit www.bonitobrazil.com.br.





For more information on the SBCBM, visit www.sbcbm.org.br.

AUTHOR AFFILIATION: Dr. Cohen is President of the 1st Panamerican Congress of Diabetes Surgery. Dr. Berti is President of the XI National Meeting of The Brazilian Society of Bariatric and Metabolic Surgery (SBCBM). Dr. Szego is President of the Brazilian Society of Bariatric and Metabolic Surgery (SBCBM)